You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Liver conditions
  5. Chronic liver disease

Seladelpar for previously treated primary biliary cholangitis [ID6429]

  • In development
  • Reference number: GID-TA11540
  • Expected publication date:  05 November 2025
  • Project information
  • Project documents
  • Consultation

On this page

  1. Draft guidance
  2. Invitation to participate
  3. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6429

Documents

Documents created during the development process.

Draft guidance

  • Draft guidance

  • Draft guidance (downloadable version) (PDF 232 KB)

    Published:
    30 July 2025
  • Draft guidance (online commenting)

  • Committee papers (PDF 9.51 MB)

    Published:
    30 July 2025
  • Public committee slides (PDF 713 KB)

    Published:
    30 July 2025
  • Equality impact assessment (downloadable version) (PDF 133 KB)

    Published:
    30 July 2025
  • Final scope (PDF 141 KB)

    Published:
    30 July 2025

Invitation to participate

  • Final scope (PDF 138 KB)

    Published:
    19 November 2024
  • Final stakeholder list (PDF 132 KB)

    Published:
    19 November 2024
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 136 KB)

    Published:
    19 November 2024
  • Equality impact assessment (scoping) (PDF 100 KB)

    Published:
    19 November 2024

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6429

  • Draft matrix post referral (PDF 176 KB)

    Published:
    03 September 2024
  • Draft scope post referral (PDF 202 KB)

    Published:
    03 September 2024
Back to top